# A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

> **NCT07300189** · PHASE1 · RECRUITING · sponsor: **OrsoBio, Inc** · enrollment: 288 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** TLC-1180 Oral Solution
- **DRUG:** TLC-1180 Tablet
- **OTHER:** Placebo Oral Solution
- **OTHER:** Placebo Tablet

## Key facts

- **NCT ID:** NCT07300189
- **Lead sponsor:** OrsoBio, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-20
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300189, "A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07300189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*